[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fundación Judío Panameña (JUPA)\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100648131","suicidal-risk-in-adults-in-panama-validation-of-a-clinical-intervention-protocol-100648131",false,"NCT07717320","Suicidal Risk in Adults in Panama: Validation of a Clinical Intervention Protocol","Inclusion Criteria:\n\n* Age and consent\n* Presence of suicidal ideation or active behavior in the last month, assessed using the C-SSRS (e.g., intentional ideation, plan, or preparatory behavior)\n* Depressive or anxious symptoms (Score ≥ 10 on the PHQ-9, indicating at least moderate depressive symptoms, or Score ≥ 10 on the GAD-7, suggesting clinically significant anxiety.)\n* Availability and commitment to participate in the full assessment using all the aforementioned scales.\n\nExclusion Criteria:\n\n* Clinical Safety (exclude and refer immediately)\n* Imminent suicide risk according to the C-SSRS (e.g., attempt within the last 7 days, current intentional plan, access to lethal means, and low ambivalence).\n* PHQ-9 item 9 = 3 (\"almost every day\") with clinical corroboration of imminent risk.\n* Current self-harm with lethality\u002Fhigh-harm moderator requiring acute restraint.\n* Refusal to establish a safety plan or allow emergency contact.\n* Acute Psychiatric Conditions\u002FContraindications of Assessment\n* Active psychosis or unstabilized manic episode.\n* Substance use disorder in intoxication or acute withdrawal (e.g., last 24-72 hours) that precludes valid assessment.\n* Uncontrolled risk of severe other-directed violence.\n* Medical or neurological conditions that preclude valid participation\n* Severe cognitive impairment (e.g., dementia, recent moderate-to-severe traumatic brain injury) that prevents understanding\u002Fanswering scales.\n* Decompensated medical illness (e.g., desaturation, delirium, severe uncontrolled pain).\n* Unstable neurological condition (e.g., uncontrolled seizures).\n* Methodological interferences\n* Recent changes in baseline psychotropic medications within the last 2 weeks.\n* Concurrent intensive psychotherapy initiated within the last 4 weeks.\n* Simultaneous participation in another trial that could contaminate results.\n* Language other than that of the scales without available validation.\n* Logistical impossibility for follow-up (no telephone\u002Fstable contact; imminent relocation plan).\n* Legal aspects\u002Fconsent\n* Incapacity to consent (legal or clinical) and no available representative.\n* Legal restrictions that prevent participation.","ALL","18 Years","60 Years",{"count":19,"type":20},300,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to validate MBT as an effective and viable intervention for implementation in public health services, with the potential to directly impact suicide prevention policies in the region.",[26],"Suicide Risk",[28,29,30,31],"Psychotherapy","Clinical Trial","Reflective Function","Public Health","NOT_YET_RECRUITING","2026-07-23",{"date":35,"type":36},"2026-07-27","ACTUAL",{"date":38,"type":20},"2026-11-01",{"date":40,"type":20},"2028-05-01",{"name":42,"class":43},"Fundación Judío Panameña (JUPA)","OTHER",2,""]